These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15256680)

  • 1. Mouse model of microembolic stroke and reperfusion.
    Atochin DN; Murciano JC; Gürsoy-Ozdemir Y; Krasik T; Noda F; Ayata C; Dunn AK; Moskowitz MA; Huang PL; Muzykantov VR
    Stroke; 2004 Sep; 35(9):2177-82. PubMed ID: 15256680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
    Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
    Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.
    Tabrizi P; Wang L; Seeds N; McComb JG; Yamada S; Griffin JH; Carmeliet P; Weiss MH; Zlokovic BV
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2801-6. PubMed ID: 10559029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
    García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
    Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mouse model of thromboembolic stroke.
    Chen Y; Zhu W; Zhang W; Libal N; Murphy SJ; Offner H; Alkayed NJ
    J Neurosci Methods; 2015 Dec; 256():203-11. PubMed ID: 26386284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
    Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
    Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
    Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of in situ thromboembolic stroke and reperfusion.
    Orset C; Macrez R; Young AR; Panthou D; Angles-Cano E; Maubert E; Agin V; Vivien D
    Stroke; 2007 Oct; 38(10):2771-8. PubMed ID: 17702959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice.
    Nagai N; Zhao BQ; Suzuki Y; Ihara H; Urano T; Umemura K
    J Cereb Blood Flow Metab; 2002 Jun; 22(6):648-51. PubMed ID: 12045662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inapparent hemodynamic insufficiency exacerbates ischemic damage in a rat microembolic stroke model.
    Omae T; Mayzel-Oreg O; Li F; Sotak CH; Fisher M
    Stroke; 2000 Oct; 31(10):2494-9. PubMed ID: 11022084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke.
    García-Yébenes I; Sobrado M; Zarruk JG; Castellanos M; Pérez de la Ossa N; Dávalos A; Serena J; Lizasoain I; Moro MA
    Stroke; 2011 Jan; 42(1):196-203. PubMed ID: 21106952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
    Takamiya M; Miyamoto Y; Yamashita T; Deguchi K; Ohta Y; Abe K
    Neuroscience; 2012 Sep; 221():47-55. PubMed ID: 22766232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
    Denorme F; Wyseure T; Peeters M; Vandeputte N; Gils A; Deckmyn H; Vanhoorelbeke K; Declerck PJ; De Meyer SF
    Stroke; 2016 Sep; 47(9):2419-22. PubMed ID: 27470988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin.
    Reed GL; Houng AK; Wang D
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2586-93. PubMed ID: 25256235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.
    Berny-Lang MA; Hurst S; Tucker EI; Pelc LA; Wang RK; Hurn PD; Di Cera E; McCarty OJ; Gruber A
    Stroke; 2011 Jun; 42(6):1736-41. PubMed ID: 21512172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.